Chindex International, Inc. (Chindex International) has signed a contract to supply EUR5 million in laboratory and hospital products to Centers for Disease Control (CDC) in China's Qinghai Province. The purchase is being financed by the KfW Development Bank of Germany under a government to government program.
Roberta Lipson, Chindex president and chief executive officer, commented, Chindex continues to be a key supplier under the KfW program’s Centers for Disease Control efforts in China. We are pleased to once again be implementing another KfW program, utilizing the expertise that we have developed in government-sponsored loan projects, to provide an increasingly diversified and robust array of medical and laboratory products to China’s healthcare communities.
Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong.